Puricell Lab

Puricell Lab is a South Korean biotechnology company specializing in the development of next-generation exosome-based therapeutics and regenerative medicine. The company leverages its proprietary "Puri-Exo" platform to isolate and mass-produce high-purity exosomes derived from stem cells, targeting a wide range of conditions including atopic dermatitis, alopecia, and inflammatory diseases. By integrating advanced stem cell culture techniques with efficient purification technologies, Puricell Lab aims to overcome the limitations of traditional cell therapies. Their pipeline includes both aesthetic applications for skin and hair rejuvenation as well as clinical treatments for chronic inflammatory disorders. The company was founded by experts from Yonsei University and has secured significant venture capital funding to advance its lead programs into clinical development.